🇺🇸 FDA
Patent

US 11111238

Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

granted A61KA61K45/06

Quick answer

US patent 11111238 (Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer) held by Lead Discovery Center GmbH expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lead Discovery Center GmbH
Grant date
Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K45/06